Cost effectiveness of atazanavir-ritonavir versus lopinavir-ritonavir in treatment-naïve human immunodeficiency virus-infected patients in the United States

Nav

General Info

Geography

United States of America (USA)

Coverage type

Country

Time period covered

01/2008 - 12/2011

Data type

Scientific literature

Keywords

HIV and AIDS, Health care costs, Health care expenditures

Citation

Authors

Broder MS, Chang EY, Bentley TG, Juday T, Uy J

Journal

J Med Econ

Volume

Issue

Pages

167-78

Publication year

2011

Suggested citation

Broder MS, Chang EY, Bentley TG, Juday T, Uy J. Cost effectiveness of atazanavir-ritonavir versus lopinavir-ritonavir in treatment-naïve human immunodeficiency virus-infected patients in the United States. J Med Econ. 2011; 14(2): 167-78.

DOI

10.3111/13696998.2011.554932

PMID

21288058

GHDx Entry last modified on: Apr 10, 2023

Header sites

Search form

Main menu

Cost effectiveness of atazanavir-ritonavir versus lopinavir-ritonavir in treatment-naïve human immunodeficiency virus-infected patients in the United States

Nav